Elanco Animal Health Reports Third-Quarter Revenue of $1.26 Billion

Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio MilestoneINDIANAPOLIS, Nov. 6, 2026 // -- Elanco Animal Health Incorporated (NYSE:ELAN) today reported financial resul…

Nov 06 (Reuters) - Elanco Animal Health Q3 net income USD 18 million.

Elanco Animal Health reported third-quarter 2026 revenue of $1.265 billion, up 11% year over year, and adjusted diluted EPS of $0.27. Reported net income was $18 million, compared with a net loss a year earlier. The company raised its full-year revenue, adjusted EBITDA and adjusted EPS guidance.Fin…